Fostemsavir Doxorubicin 28

Rukobia package insert

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits benefit
Drug 1
Drug 2
Clinical Effects

Increased exposure of doxorubicin

Management

If co-adminstering, monitor for adverse effects

Import ID
28